U.S. HIV TESTING DAY: LET'S STOP HIV TOGETHER

National HIV Testing Day is June 27, 2020 and for some Americans, it could be the
most important day of their lives.

U.S. HIV TESTING DAY: LET'S STOP HIV TOGETHER

National HIV Testing Day is June 27, 2020 and for some Americans, it could be the most important day of their lives.

THE IMPORTANCE OF EARLY HIV DIAGNOSIS

The sooner the HIV virus can be detected, the faster the right treatment can be provided, improving both patient
outcomes and quality of life.¹

Early intervention also helps prevent the transmission of the virus. Nearly 1 in 7 HIV-positive Americans don’t know
they are infected — and these individuals are responsible for as much as 80% of new HIV infections.²‚³

THE IMPORTANCE OF EARLY HIV DIAGNOSIS

The sooner the HIV virus can be detected, the faster the right treatment can be provided, improving both patient
outcomes and quality of life.¹

Early intervention also helps prevent the transmission of the virus. Nearly 1 in 7 HIV-positive Americans don’t know
they are infected — and these individuals are responsible for as much as 80% of new HIV infections.²‚³

DETERMINE ™ HIV-1/2 AG/AB COMBO

Enables detection of HIV earlier at the point-of-care.

Determine™ HIV-1/2 Ag/Ab Combo is a 4th generation test that has the ability to detect HIV earlier than 2nd and 3rd generation antibody-only tests.6 It is the first and only FDA approved rapid point-of-care test that simultaneously and separately detects HIV-1/2 antibodies and free HIV-1 p24 antigen on a single test strip.

  • Easy – Determine™ HIV-1/2 Ag/Ab Combo requires minimal training and no expensive lab equipment. Quality controls are built-in and let you know the test is working properly.
  • Fast – Enables health care providers to diagnose HIV infection earlier allowing individuals to seek medical care sooner. Test results are ready in just 20 minutes.
  • Flexible – Made for the point of care, Determine™ HIV-1/2 Ag/Ab Combo is designed for testing with fingerstick and venous whole blood, serum and plasma samples.
    This test is currently CLIA-waived for fingerstick whole blood.

DETERMINE ™ HIV-1/2 AG/AB COMBO

Enables detection of HIV earlier at the point-of-care.

Determine™ HIV-1/2 Ag/Ab Combo is a 4th generation test that has the ability to detect HIV earlier than 2nd and 3rd generation antibody-only tests.6 It is the first and only FDA approved rapid point-of-care test that simultaneously and separately detects HIV-1/2 antibodies and free HIV-1 p24 antigen on a single test strip.

  • Easy – Determine™ HIV-1/2 Ag/Ab Combo requires minimal training and no expensive lab equipment. Quality controls are built-in and let you know the test is working properly.
  • Fast – Enables health care providers to diagnose HIV infection earlier allowing individuals to seek medical care sooner. Test results are ready in just 20 minutes.
  • Flexible – Made for the point of care, Determine™ HIV-1/2 Ag/Ab Combo is designed for testing with fingerstick and venous whole blood, serum and plasma samples.
    This test is currently CLIA-waived for fingerstick whole blood.

STAY INFORMED

Sign up to receive valuable updates from Abbott.

STAY INFORMED

Sign up to receive valuable updates from Abbott.

©2020 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy: US Citizens | Non US CitizensPhotos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. 120004229-03 06/20

©2020 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy: US Citizens | Non US CitizensPhotos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. 120004229-03 06/20